Safety of Intravenous Lidocaine Infusions
Safety of Intravenous Lidocaine Infusions for Chronic Neuropathic Pain
研究概览
地位
条件
详细说明
Eligibility Criteria:
Adults > 18 yrs with chronic central or peripheral neuropathic pain at the St Joseph's Health Care Pain Clinic between June and December 2009.
Outcome measures: All side effects spontaneously reported. Sedation, nausea, dizziness by Visual Analog Score Q 15 minutes; hemodynamic data q 5 minutes during and after infusion for 30 minutes.
Daily diary of side effects and Visual Analogue score of Pain for 7 days post-infusion.
研究类型
注册 (实际的)
联系人和位置
学习地点
-
-
Ontario
-
London、Ontario、加拿大、N6A 4V2
- St Joseph's Health Care
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- Adult outpatients > 18 years < 80 years diagnosed with chronic neuropathic pain
Exclusion Criteria:
- Unable to provide informed consent
- Unable to speak and understand English
- Liver, kidney, or cardiac failure
- Allergy to Lidocaine
学习计划
研究是如何设计的？
设计细节
队列和干预
团体/队列 |
|---|
|
Lidocaine
Adults >18 yrs , attending St Joseph's Health Care Pain Clinic with a diagnosis of chronic neuropathic pain who are being treated with an lidocaine infusion of 5 mg/kg over 45 minutes Consecutive patients from two time periods:
|
合作者和调查者
调查人员
- 首席研究员：Patricia K Morley-Forster, MD, FRCPC、Associate Professor,Dept of Anesthesia and Perioperative Medicine,University of Western Ontario, Lawson Health Research Institute
- 首席研究员：Patricia K Morley-Forster, MD, FRCPC、Associate Professor, University of Western Ontario, Lawson Health Research Institute
出版物和有用的链接
研究记录日期
研究主要日期
学习开始
初级完成 (实际的)
研究完成 (实际的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.